Pago Aylés Immortalis Viñas de Altura Priorat Garnatxa 2022

Priorat's unique terroir of steep, rocky slopes and ancient slate soils creates some of Spain's most concentrated wines. The harsh conditions force vines to struggle, sending roots deep into the mineral-rich llicorella (slate) to find water and nutrients. This stress produces smaller yields but incredibly intense fruit with distinctive mineral complexity that you simply can't replicate elsewhere.

The name 'Immortalis' reflects the enduring character of Priorat's ancient vines and the wine's age-worthy potential. 'Viñas de Altura' translates to 'high altitude vineyards', referring to the elevated vineyard sites that benefit from cooler temperatures and greater diurnal variation. This altitude helps preserve acidity while allowing full phenolic ripeness, creating the wine's signature balance of power and freshness.

While Australian Shiraz tends toward ripe, jammy fruit and chocolate notes, Priorat's version shows more restraint and mineral complexity. The slate soils and Mediterranean climate with cool nights create a Shiraz with darker fruit flavours like black cherry, plus distinctive herbal and floral notes like violets and liquorice. The tannin structure is firmer and more structured, reflecting the region's ability to produce elegant yet powerful expressions.

This wine's savoury, textured profile makes it perfect for rich, flavourful dishes that can match its intensity. Think grilled lamb with rosemary, aged beef steaks, or hearty stews with root vegetables. The wine's mineral backbone and firm tannins also complement hard cheeses like aged Manchego, while its fruit concentration pairs beautifully with game meats or even dark chocolate desserts.

The 2022 is drinking beautifully now, showing vibrant fruit and well-integrated tannins that make it approachable in its youth. However, Priorat wines are renowned for their ageing potential - this Immortalis will continue developing complexity over the next 8-10 years. The wine's excellent ratings from critics like James Suckling suggest it has the structure and balance to reward patient cellaring, evolving into something even more sophisticated with time.